Product Introduction
Bioactivity


英文名: Elagolix sodium

描述: Elagolix sodium (NBI-56418 sodium) 是人GnRH 受体拮抗剂，其IC50=0.25 nM，Ki=3.7 nM。

体内活性: Elagolix sodium 用于治疗中度至重度子宫内膜异位症相关疼痛的女性[1]。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (76.50 mM)
H2O : 50 mg/mL (76.50 mM)


关键字: Gonadotropin releasing hormone receptor | inhibit | NBI-56418 | GnRH Receptor | NBI 56418 | Elagolix | GNRHR | Inhibitor | Elagolix sodium | NBI56418

相关产品: LGnRH-III, lamprey acetate(147859-97-0 free base) | Deslorelin acetate(57773-65-6 free base) | Lecirelin acetate(61012-19-9 free base) | Phoenixin-14 | Buserelin Acetate (57982-77-1 free base) | Alarelin Acetate | GnRH-R antagonist 1 | Abarelix | Triptorelin acetate(57773-63-4 free base) | Goserelin acetate

相关库: Drug Repurposing Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | GPCR Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Approved Drug Library